β-Lactam Antibiotics: Structure, Mechanism, and Resistance
β-Lactam antibiotics are among the most important and widely used antimicrobial agents. Their discovery in the 1930s and development throughout the 20th century revolutionized the treatment of bacterial infections. All β-lactam antibiotics share a core structural feature: the β-lactam ring, which is essential for their antibacterial activity.
Structure and Subclasses
The β-lactam ring is a four-membered cyclic amide (azetidinone) that is chemically reactive due to ring strain. Variations in side chains and additional fused rings lead to the formation of different β-lactam subclasses:
-
Penicillins (e.g., penicillin G, ampicillin)
→ Saturated five-membered ring fused to β-lactam -
Cephalosporins (e.g., cefotaxime)
→ Unsaturated six-membered ring fused to β-lactam -
Carbapenems (e.g., imipenem, PZ-601)
→ Unsaturated five-membered ring with broader spectrum -
Monobactams (e.g., aztreonam)
→ Contain only the β-lactam ring without fusion to another ring
All β-lactams inhibit bacterial cell wall biosynthesis by binding to penicillin-binding proteins (PBPs)—enzymes responsible for the final cross-linking of peptidoglycan strands. By inactivating PBPs, β-lactams prevent proper cell wall formation, leading to cell lysis and death.
Resistance Mechanisms
Bacterial resistance to β-lactam antibiotics can arise through several mechanisms:
-
Production of β-lactamases: Enzymes that hydrolyze the β-lactam ring (e.g., penicillinase, cephalosporinase).
-
Modification of PBPs: Some bacteria, such as MRSA, produce altered PBPs with reduced affinity for β-lactams.
-
Decreased permeability or efflux: Especially in Gram-negative bacteria, outer membrane porins may be lost or altered to prevent drug entry, or active efflux systems remove the antibiotic from the cell.
To counteract resistance, β-lactamase inhibitors such as clavulanic acid, sulbactam, and tazobactam are used in combination with β-lactam antibiotics. New inhibitors like BAL29880 (β-lactam-based) and NXL104 (non-β-lactam) have also been developed
New Developments
The development of semisynthetic and next-generation β-lactams has produced drugs such as:
-
CXA-101: A cephalosporin with potent activity against Pseudomonas aeruginosa
-
Ceftaroline and ceftobiprole: 5th-generation cephalosporins effective against MRSA
-
ME-1036 and PZ-601: Carbapenems with improved activity against resistant strains
- BAL-30072: A monobactam with a siderophore group for improved bacterial uptake.
β-Lactam antibiotics are used to treat:
-
Respiratory tract infections
-
Urinary tract infections
-
Skin and soft tissue infections
-
Sepsis and meningitis
They are typically well-tolerated, though allergic reactions (especially to penicillin) are common.
References
All information presented in this article is based on:
Maffioli, Sonia Ilaria. “A Chemist’s Survey of Different Antibiotic Classes.” In Antibiotics: Targets, Mechanisms and Resistance, edited by Claudio O. Gualerzi, Letizia Brandi, Attilio Fabbretti, and Cynthia L. Pon, Wiley-VCH Verlag GmbH & Co. KGaA, 2014, pp. 1–4.
Note:
- This article is still under development, and the information it contains may change as scientific research progresses.
- Please be aware that specific details presented in this source may vary and require direct access to the original source for further information about the content described.
Komentar
Posting Komentar